Table 4 Postoperative complications, presented as no. (%)
From: Allograft tolerance after adult living donor liver transplantation: a case-control study
|  | Tolerance Group (N = 275) | Non-Tolerant Group (N = 93) | P-value |
|---|---|---|---|
ACR | 114 (41.5%) | 63 (67.7%) | < 0.001* |
ACR frequency |  |  | < 0.001* |
 0  1  2  3  4  6 | 161 (58.5%) 83 (30.2%) 22 (8%) 8 (2.9%) 1 (0.4%) 0 | 30 (32.3%) 33 (35.5%) 20 (21.5%) 6 (6.5%) 3 (3.2%) 1 (1.1%) | |
Recurrent viral hepatitis | 62 (22.5%) | 37 (39.8%) | 0.001* |
Recurrent viral hepatitis frequency | Â | Â | 0.001* |
 0  1  2  3  4  5 | 213 (77.5%) 50 (18.2%) 9 (3.3%) 2 (0.7%) 0 1 (0.4%) | 56 (60.2%) 22 (23.7%) 10 (10.8%) 4 (4.3%) 1 (1.1%) 0 | |
Biliary Complications | 72 (26.2%) | 50 (53.8%) | < 0.001* |